Country Support Manager Job at Clinton Health Access Initiative, Inc.
Founded in 2002 by President William J. Clinton, the Clinton Health
Access Initiative (CHAI) works to broaden access to life-saving
treatment for HIV/AIDS, tuberculosis and malaria patients in the poorest
parts of the world. As part of this mission, CHAI’s “Access Programs”
approach global
public health challenges with market-based strategies,
using simultaneous engagement on both the supply and demand sides of the
market. On the supply side, CHAI engages with suppliers of essential
drugs and diagnostics to improve access to products by lowering prices,
accelerating new products to market, and sharing market intelligence. On
the demand side, CHAI organizes and consolidates demand for health
commodities by helping governments to scale up treatment programs,
mobilize new resources, improve procurement processes, and enhance local
human resource capacity. Working with over 30 governments and other
partners, CHAI is focused on large-scale impact on many of the largest
barriers to effective treatment and care.
The Laboratory Services
Team (LST) is a key source of support for Ministries of Health and
CHAI's country teams, and works to address barriers to access and foster
a healthy competitive marketplace for essential diagnostic testing. LST
plays the lead role in coordinating work globally on access to
diagnostics, working closely with diagnostics manufacturers,
governments, and multilateral organizations to lower prices, increase
access to testing, and accelerate the entry and uptake of new innovative
products.
Job Title: Country Support Manager
The
Country Support Manager (CSM) will work with LST to ensure the rapid
scale-up and effective management of high-quality diagnostics for high
burden diseases, focusing primarily on diagnostics for patients with HIV
and TB. The CSM will work with Ministries of Health and CHAI country
teams across multiple focal countries, helping to optimize policies and
processes, expand access to high quality diagnostics, ensure that
countries have adopted best practices in planning and implementation of
testing programs, and support forecasting and procurement of essential
diagnostic products. The CSM will also provide support in the
quantification and mapping of funding needs against available resources,
helping the government to identify funding gaps and design
interventions and scale up plans in consideration of current resources.
Historically,
the majority of diagnostic testing for HIV and TB has been conducted on
conventional, laboratory-based technologies using sample transportation
systems to expand access to testing to patients living in rural areas.
However, access to these products is limited in many countries, and
Ministries of Health require continued support to improve the efficiency
of these technologies, expand their reach, and introduce new types of
essential tests. In addition, several POC products for diagnosis,
disease staging, and treatment monitoring have recently become available
or are in development, with the potential to dramatically increase
access to treatment, improve patient retention, and make healthcare
systems more efficient. These technologies need to be integrated with
existing conventional laboratory networks, with an appropriate balance
between centralized and decentralized testing.
The CSM will
support countries in the implementation of both conventional,
laboratory-based diagnostic products and new, innovative point-of-care
(POC) products that bring diagnostics out of the laboratory and closer
to the patient. In particular, The CSM will support countries in
adopting the recently published WHO 2013 guidelines, including the use
of viral load (VL) for monitoring patients on anti-retroviral therapy
(ART), and developing strategies for scaling up testing programs, which
include HIV diagnosis, CD4 testing, Early Infant Diagnosis (EID) and
other opportunistic infections. In addition, the CSM will assist
countries with the evaluation, adoption and uptake of new POC diagnostic
products, which can reduce the burden of undergoing testing, and
improve access to essential tests, particularly in rural areas.
The
CSM will also support LST in global negotiations with diagnostics
manufacturers to lower prices, and with the development of new
procurement strategies such as instrument rental deals to enable easier
product switching. Finally, the CSM will help develop LST’s
market-shaping strategy for fostering competition in the global
diagnostics market. In doing so, the CSM will develop strong
relationships with various teams within CHAI, as well as Ministries of
Health, diagnostics manufacturers, and other external partners in
beneficiary countries.
We are seeking a highly motivated
individual with outstanding credentials, qualitative and quantitative
analytical abilities, and communication skills. The CSM must be able to
function independently and flexibly and have a strong commitment to
excellence. CHAI places great value on relevant personal qualities:
resourcefulness, responsibility, tenacity, independence, energy, work
ethic and emotional intelligence.
This is a challenging but
rewarding role, which will have direct and near-term impact on thousands
of patients in need of life-saving health services. The role will be
based in Nigeria with up to 50% travel in the region.
Responsibilities
- Serve
as a key advisor to Ministries of Health, CHAI country teams, and
in-country and global partners on the expansion of access to diagnostic
testing, and the adoption of new diagnostic products and their
integration into existing laboratory networks
- Manage and coordinate diagnostics projects across multiple CHAI focal countries, with multiple work streams in each country
- Act as the focal point to manage the relationship between LST and CHAI country teams, including country team leadership
- Share
best practices across country program to ensure knowledge is shared on
the strategies, tools and experiences of all programs
- Support countries in the adoption of the recently published WHO 2013 guidelines
- Support
countries in the development of strategic and implementation plans for
HIV diagnosis in adults and children, including EID, CD4 and VL testing.
- Support the adoption of current and new HIV and TB diagnostic products and their integration into existing lab networks
- Assist
Ministries of Health to build capacity to perform technical evaluations
to drive regulatory approvals and ensure that new technologies perform
accurately, conduct operational pilots to demonstrate the cost
effectiveness and impact of new products on patient outcomes, and assist
with analysis and writing of evaluation reports
- Develop and share deployment models and strategies for how to maximize the impact of existing and new diagnostic technologies
- Prepare impact analysis and build tools (forecasting, budgeting, work plans, etc.) to support countries’ activities
- Assist
Ministries of Health in the development of testing policies and
national implementation plans, and the creation of operational systems
to support the wide-scale implementation of new and existing diagnostic
products, such as training, quality assurance, and data management
- Work with CHAI country teams, governments, and partners to identify funding for increased investment in new diagnostic products
- Design
and implement monitoring and evaluation (M&E) systems to measure
the impact of new and existing technologies and assess progress against
project goals
- Assist LST to manage global supplier relationships
through product demand forecasting, market analysis, sharing of market
intelligence, and supporting price negotiations
- Provide remote
and in-country technical assistance to CHAI country teams and
governments in support of work streams related to diagnostics
Pluses
- Previous CHAI experience
- Policy and program management experience
- Experience supporting governments in implementing health systems in resource-limited settings
- Experience working in management consulting, investment banking, or similar environment
- Experience living or working abroad, particularly in developing countries
- Demonstrated
success in training, coaching and supporting fellow team members and
partners at all levels of an organization to build capacity in a
sustainable manner
- Familiarity with global health issues, particularly HIV/AIDS and TB
The
Country Support Manager (CSM) will work with LST to ensure the rapid
scale-up and effective management of high-quality diagnostics for high
burden diseases, focusing primarily on diagnostics for patients with HIV
and TB. The CSM will work with Ministries of Health and CHAI country
teams across multiple focal countries, helping to optimize policies and
processes, expand access to high quality diagnostics, ensure that
countries have adopted best practices in planning and implementation of
testing programs, and support forecasting and procurement of essential
diagnostic products. The CSM will also provide support in the
quantification and mapping of funding needs against available resources,
helping the government to identify funding gaps and design
interventions and scale up plans in consideration of current resources.
Historically,
the majority of diagnostic testing for HIV and TB has been conducted on
conventional, laboratory-based technologies using sample transportation
systems to expand access to testing to patients living in rural areas.
However, access to these products is limited in many countries, and
Ministries of Health require continued support to improve the efficiency
of these technologies, expand their reach, and introduce new types of
essential tests. In addition, several POC products for diagnosis,
disease staging, and treatment monitoring have recently become available
or are in development, with the potential to dramatically increase
access to treatment, improve patient retention, and make healthcare
systems more efficient. These technologies need to be integrated with
existing conventional laboratory networks, with an appropriate balance
between centralized and decentralized testing.
The CSM will
support countries in the implementation of both conventional,
laboratory-based diagnostic products and new, innovative point-of-care
(POC) products that bring diagnostics out of the laboratory and closer
to the patient. In particular, The CSM will support countries in
adopting the recently published WHO 2013 guidelines, including the use
of viral load (VL) for monitoring patients on anti-retroviral therapy
(ART), and developing strategies for scaling up testing programs, which
include HIV diagnosis, CD4 testing, Early Infant Diagnosis (EID) and
other opportunistic infections. In addition, the CSM will assist
countries with the evaluation, adoption and uptake of new POC diagnostic
products, which can reduce the burden of undergoing testing, and
improve access to essential tests, particularly in rural areas.
The
CSM will also support LST in global negotiations with diagnostics
manufacturers to lower prices, and with the development of new
procurement strategies such as instrument rental deals to enable easier
product switching. Finally, the CSM will help develop LST’s
market-shaping strategy for fostering competition in the global
diagnostics market. In doing so, the CSM will develop strong
relationships with various teams within CHAI, as well as Ministries of
Health, diagnostics manufacturers, and other external partners in
beneficiary countries.
We are seeking a highly motivated
individual with outstanding credentials, qualitative and quantitative
analytical abilities, and communication skills. The CSM must be able to
function independently and flexibly and have a strong commitment to
excellence. CHAI places great value on relevant personal qualities:
resourcefulness, responsibility, tenacity, independence, energy, work
ethic and emotional intelligence.
This is a challenging but
rewarding role, which will have direct and near-term impact on thousands
of patients in need of life-saving health services. The role will be
based in Nigeria with up to 50% travel in the region.
How to Apply
Interested and qualified candidates should
Click Here to Apply